PET-CT and axillary staging
Axillary Node Uptake on — Breast Cancer PET
When a PET scan shows uptake in axillary lymph nodes, the natural fear is that cancer has spread there. That finding needs careful interpretation — and it needs tissue confirmation before any treatment decision is made.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026
- Uptake is not a diagnosis — PET shows metabolic activity, not cancer cells. A biopsy or sentinel node procedure is needed to confirm what the uptake means.
- PET misses small deposits — Micrometastases — tiny deposits of cancer cells — are often below PET resolution. A clear scan does not rule out nodal spread.
- Sentinel biopsy still matters — NCCN and ASCO do not support replacing sentinel node biopsy with PET-CT. The two tests answer different questions.
- PET is not for early breast cancer — For Stage I and Stage II disease, PET is not part of routine staging. It is most useful in locally advanced and metastatic cases.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Uptake in axillary lymph nodes on a PET scan means the scanner detected increased metabolic activity there. This can indicate cancer cells in the nodes — but it is not a confirmed diagnosis. PET cannot detect small deposits reliably, and NCCN and ASCO guidance is clear that sentinel node biopsy remains the standard for axillary staging.
At CION, a whole-body PET-CT starts from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.
What happens after a PET scan shows uptake in axillary nodes?
Your oncologist reviews the full picture
The axillary finding is read alongside your tumour size, grade, receptor status, and clinical examination. No single scan finding is interpreted in isolation.
An axillary ultrasound is usually arranged
Ultrasound can characterise suspicious nodes in more detail. A node that looks abnormal on ultrasound may be sampled with a fine needle at the same appointment.
Tissue is taken from the node
This may be an ultrasound-guided fine-needle aspiration, a core biopsy, or a sentinel node biopsy in the operating theatre. Your team will recommend the approach that fits your situation.
Pathology confirms whether cancer cells are present
The laboratory result — not the PET scan — determines whether the node contains cancer. That is what the PET finding triggers, not replaces.
Treatment planning uses the confirmed result
Your oncologist will incorporate the pathology into the full staging picture and explain what it means for surgery, chemotherapy, and radiation.
What does it mean when a lymph node lights up on a PET scan?
A PET scan measures metabolic activity — how quickly cells are consuming glucose. Cancer cells tend to use more glucose than normal cells, which is why they often appear brighter on the scan.
Axillary uptake means those nodes were metabolically active at the time of the scan. That can happen because cancer cells are present. It can also happen because of infection, inflammation, a recent vaccination in that arm, or reactive change following biopsy.
This is why uptake is a prompt for investigation, not a conclusion. Your oncologist will consider how intense the uptake is, how many nodes are involved, and what the rest of your clinical picture looks like before deciding what to do next.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
Is sentinel node biopsy still needed after PET shows axillary uptake?
Yes — and this is one of the most commonly misunderstood points in breast cancer imaging. NCCN and ASCO guidance does not support replacing sentinel node biopsy with PET-CT for axillary staging.
PET is sensitive to larger or more metabolically active deposits, but it misses small ones. Deposits too small for PET to detect can still be large enough to affect decisions about chemotherapy and radiation. Sentinel node biopsy samples the actual tissue and examines it microscopically, which makes it more sensitive for small-volume disease.
If PET shows uptake, your team may use that finding to guide which nodes to sample. But pathological confirmation is still required before any decision about axillary surgery or treatment intensity is made.
What do the terms in a PET report mean?
- Axillary nodes
- Lymph nodes in the armpit that drain fluid — and potentially cancer cells — from the breast. Their status is one of the most important factors in staging and in decisions about chemotherapy and radiation.
- PET uptake
- A signal where cells are consuming glucose more actively than the surrounding tissue, shown as a bright area on the image. High uptake is suspicious but not specific — it can be caused by cancer, infection, or inflammation.
- SUV (Standardised Uptake Value)
- A number that measures the intensity of the PET signal in a given area. A higher number suggests more metabolic activity. No SUV value alone confirms or excludes cancer — it is one piece of information, not a diagnosis.
- Sentinel node biopsy
- A surgical procedure in which a tracer or dye identifies the first lymph nodes draining the tumour. Those nodes are removed and examined in detail by a pathologist. If they contain no cancer cells, the remaining axillary nodes are generally considered clear.
- Micrometastasis
- A very small deposit of cancer cells in a lymph node — small enough that PET cannot reliably detect it. Sentinel node biopsy, with careful pathological analysis of the tissue, is how micrometastases are found.
Questions families ask about axillary nodes and PET
Can PET tell the difference between cancer and infection in a lymph node?
Not reliably. Both cancer and infection cause lymph nodes to become metabolically active and can appear bright on PET. A recent cold, a skin infection on the arm, or a vaccination on that side in the weeks before the scan can all produce axillary uptake. This is why the finding is always read alongside the clinical picture, and why tissue sampling is the only way to confirm what is causing it.
If PET shows clear axillary nodes, does that mean no cancer has spread there?
Not necessarily. A clear PET in the axilla reduces suspicion, but it does not rule out nodal spread. PET has a resolution limit — deposits below a certain size do not generate enough signal to appear on the scan. In breast cancer, very small nodal deposits are common and clinically important. A clear PET does not remove the need for sentinel node biopsy if your surgeon has recommended it.
Why is PET not part of routine staging for early breast cancer?
For Stage I and Stage II breast cancer, NCCN and ESMO guidance does not include PET-CT in routine staging. In early disease, the probability of distant spread is low, and PET is not sensitive enough at the small-volume end to replace surgical axillary staging. PET is most useful when the disease is locally advanced — Stage III — or when looking for distant spread. If PET was requested in your case, ask your oncologist what specific question it was being used to answer.
The PET report says the nodes are hypermetabolic. Is that the same as cancer?
Hypermetabolic means the nodes are more active than expected. It describes a scan finding, not a diagnosis. Radiologists use this language because it is accurate — PET cannot determine whether the activity is from cancer, reactive change, or another process. If the report says hypermetabolic and no biopsy is being planned, ask your oncologist what the next step is and why.
If axillary nodes are confirmed positive, will all of them need to be removed?
Not automatically. NCCN and ASCO guidance has shifted significantly on this. In many patients with a limited number of positive sentinel nodes who are receiving systemic treatment and radiation, further axillary surgery may not be recommended. The decision depends on how many nodes contain cancer, the size of the deposits, and the overall treatment plan. Ask your surgeon directly: how many positive nodes were found, and what does that mean for surgery in your case.
PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.
Explore 100 more PET-CT for Your Cancer Type topics
Breast Cancer PET-CT
- Axillary Node Uptake on PET for Breast Cancer
- Bone Metastases in Breast Cancer: PET or Bone Scan?
- Breastfeeding and PET-CT Scans
- Incidental Breast Uptake Found on a Scan for Something Else
- Is a PET-CT Needed for Early Breast Cancer?
- PET-CT Cost for Breast Cancer Staging in Hyderabad
- PET-CT and Breast Implants
- PET-CT for Breast Cancer Recurrence
- PET-CT for Breast Cancer: When Is It Needed?
- PET-CT for Locally Advanced Breast Cancer
- PET-CT for Triple-Negative and HER2-Positive Breast Cancer
- PET-CT to Check Response in Breast Cancer
GI, Liver & Colorectal PET-CT
- Focal Bowel Uptake: When to Do a Colonoscopy
- Mucinous Tumours: Why PET Often Misses Them
- PET-CT Before Liver Resection or HIPEC
- PET-CT Cost for GI Cancer Staging in Hyderabad
- PET-CT for Colorectal Cancer
- PET-CT for Gallbladder and Bile Duct Cancer
- PET-CT for Liver Cancer (Hepatocellular Carcinoma)
- PET-CT for Liver Metastases: How Reliable?
- PET-CT for Oesophageal and Stomach Cancer
- PET-CT for Pancreatic Cancer
- Peritoneal Spread on PET-CT: What It Can and Cannot See
- Rising CEA With Normal Scans: Where Does PET Fit?
Gynaecological Cancer PET-CT
- PET-CT After Chemoradiation for Cervical Cancer
- PET-CT Cost for Gynaecological Cancer in Hyderabad
- PET-CT and Pregnancy: Why It Is Avoided
- PET-CT for Cervical Cancer
- PET-CT for Endometrial and Uterine Cancer
- PET-CT for Gestational Trophoblastic Disease
- PET-CT for Ovarian Cancer
- PET-CT for Vulvar and Vaginal Cancer
- Para-Aortic Node Uptake in Cervical Cancer
- Physiological Uterine and Ovarian Uptake
- Rising CA-125 With Normal Scans
- Why the Bladder Makes Pelvic PET Harder to Read
Head, Neck & Thyroid PET-CT
- Dental Work, Fillings and Artefacts on Head-Neck PET
- Neck Node Uptake on PET: What It Means
- PET-CT After Radiotherapy for Head and Neck Cancer
- PET-CT Cost for Head and Neck Cancer in Hyderabad
- PET-CT for Cancer of Unknown Primary in the Neck
- PET-CT for Head and Neck Cancer
- PET-CT for Nasopharyngeal Cancer
- PET-CT for Oral Cancer Staging
- PET-CT for Salivary Gland and Sinus Tumours
- PET-CT for Thyroid Cancer: When Is It Used?
- Rising Thyroglobulin With a Negative Iodine Scan
- Vocal Cord and Muscle Uptake in the Neck
Lung Cancer PET-CT
- Adrenal Findings During Lung Cancer Staging
- Brain Metastases: Why PET Is Not Enough for Lung Cancer
- Lung Nodule With High Uptake: Cancer or TB?
- Mediastinal Nodes on PET-CT: Staging the Chest
- PET-CT After Lung Cancer Treatment
- PET-CT Before Lung Cancer Surgery
- PET-CT Cost for Lung Cancer Staging in Hyderabad
- PET-CT for Lung Cancer: What It Shows
- PET-CT for Mesothelioma
- PET-CT for Small Cell Lung Cancer
- PET-CT for a Lung Nodule: Is It Cancer?
- Pleural Effusion and Pleural Uptake on PET
Lymphoma & Blood Cancer PET-CT
- Bone Marrow Involvement on PET in Lymphoma
- Deauville Score in Lymphoma: The Complete Guide
- End-of-Treatment PET in Lymphoma
- How Many PET Scans Will a Lymphoma Patient Need?
- Interim PET in Lymphoma: The Scan That Changes Treatment
- Lymphoma Staging on PET-CT: Ann Arbor and Lugano
- PET-CT Cost Across a Lymphoma Treatment Course
- PET-CT for Hodgkin vs Non-Hodgkin Lymphoma
- PET-CT for Lymphoma: Why It Matters More Here
- PET-CT for Multiple Myeloma
- PET-CT in Leukaemia: When Is It Used?
- Residual Mass After Lymphoma Treatment: Scar or Disease?
- Surveillance PET Scans After Lymphoma Remission
- Thymic Rebound and Marrow Uptake in Young Lymphoma Patients
Non-Oncology PET-CT
- Brain PET for Dementia and Memory Loss
- Brain PET for Epilepsy and Seizure Focus
- Cardiac PET for Heart Muscle Viability
- Cardiac PET for Sarcoidosis and Inflammation
- Does a Non-Cancer PET-CT Cost the Same?
- PET-CT for Fever of Unknown Origin
- PET-CT for Non-Cancer Conditions: Why You Have Been Referred
- PET-CT for Suspected Bone or Spine Infection
- PET-CT for Suspected Infection in Implants and Grafts
- PET-CT for Unexplained Weight Loss
- PET-CT for Vasculitis and Large Vessel Inflammation
- Preparation for a Cardiac or Brain PET Scan
- What If a Non-Cancer PET Scan Finds Something Suspicious?
- Who Reports a Non-Oncology PET Scan?
Urological & Other Cancer PET-CT
- PET-CT Cost for Urological Cancers in Hyderabad
- PET-CT for Bladder Cancer
- PET-CT for Bone Metastases From Any Cancer
- PET-CT for Brain Tumours: Why MRI Comes First
- PET-CT for Kidney Cancer: Why FDG Is Unreliable
- PET-CT for Melanoma
- PET-CT for Neuroendocrine Tumours: FDG or DOTA?
- PET-CT for Paediatric Cancers
- PET-CT for Rare and Unusual Cancers
- PET-CT for Sarcoma
- PET-CT for Skin and Merkel Cell Cancers
- PET-CT for Testicular Cancer
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
What does axillary lymph node uptake mean on a breast cancer PET scan?
It means those nodes under the arm were metabolically active — consuming more glucose than the surrounding tissue — at the time of the scan. That can happen when cancer cells are present, but also with infection, inflammation, or a recent vaccination. Uptake is a signal that the nodes need closer attention, not a confirmed finding of spread. Tissue sampling, through fine-needle aspiration or sentinel node biopsy, is what determines whether cancer cells are actually there.
Does PET-CT replace sentinel node biopsy for breast cancer?
No. NCCN and ASCO guidance is clear that sentinel node biopsy remains the standard for axillary staging. Sentinel biopsy examines the tissue directly and can detect very small deposits of cancer cells that PET cannot see. A clear PET does not remove the need for sentinel node biopsy if your surgeon has recommended it. The two tests serve different purposes, and PET is not sensitive enough at the small-volume end to replace the surgical assessment.
Can PET miss lymph node spread in breast cancer?
Yes, and this matters clinically. PET has a resolution limit — very small deposits of cancer cells, called micrometastases, do not generate enough signal to appear on the scan. In breast cancer, even small nodal deposits can affect decisions about chemotherapy and radiation. This is one reason sentinel node biopsy remains part of staging even when PET has been done. A clear PET does not mean the axillary nodes are definitely free of disease.
What can cause a false positive in axillary nodes on PET?
Several things. A recent infection or inflammation in the arm or skin can make axillary nodes reactive and metabolically active. A vaccination in that arm in the weeks before the scan is a recognised cause. Recent biopsy can also produce reactive nodal change. Your team will ask about recent illnesses and injections when interpreting the scan. Where there is uncertainty, ultrasound and fine-needle aspiration can usually clarify the finding quickly.
Is PET-CT part of routine breast cancer staging?
Not for early-stage disease. For Stage I and Stage II breast cancer, NCCN and ESMO guidelines do not include PET-CT in routine staging. It is most useful in locally advanced breast cancer — Stage III — and when distant spread is being assessed or treatment response is being monitored. If PET has been requested for you, your oncologist can explain what specific clinical question it is being used to answer.
Who interprets a PET scan result for breast cancer at CION?
PET-CT scans are coordinated through CION's partner imaging centres, where nuclear medicine physicians report the images. Your oncologist at CION reviews the report alongside your pathology, clinical examination, and other imaging, and explains what the findings mean for your treatment plan. The PET report is one part of a wider picture — your team will tell you how the axillary finding sits within the full staging assessment and what happens next.